Fatty acid elongase (ELOVL) targeting to promote remyelination and central nervous system repair in multiple sclerosis
ELOVL6 inhibition enhances remyelination and reduces neuroinflammation in preclinical multiple sclerosis models. This approach targets fatty acid elongation downstream of SCD1 to avoid severe side effects, offering a pro...